列线图预测无慢加急性肝衰竭的失代偿期肝硬化患者炎症反应生物标志物的预后价值
本研究纳入902例不同病因的失代偿期肝硬化且无慢加急性肝衰竭的患者,用多因素Cox模型筛选独立预测因子并构建列线图预测生存。基于中性粒细胞与淋巴细胞比值(NLR)和淋巴细胞与单核细胞比值(LMR)的列线图在预测生存方面优于MELD评分、MELD-Na和CLIF-C ADs评分,并在验证队列中得到相似结果。
要点
- NLR>5.7或LMR≤1.1的失代偿期肝硬化患者死亡率显著更高(P<0.001)。
- 列线图预测生存的C指数高于MELD评分、MELD-Na和CLIF-C ADs评分。
- 列线图在验证队列中同样表现优于MELD评分、MELD-Na和CLIF-C ADs评分。
核心结论
- 基于NLR和LMR构建的列线图能对无ACLF的失代偿期肝硬化患者进行准确的预后预测。
研究设计与样本
- 研究纳入902例不同病因的失代偿期肝硬化且无ACLF的患者,采用多因素Cox模型筛选独立预测因子并构建列线图,用C指数和时间依赖ROC(td-ROC)分析评估并比较列线图与MELD评分、MELD-Na和CLIF-C ADs评分的性能。
主要发现
- 患者6个月、1年和3年死亡率分别为18.6%、24.4%和34.8%。
- X-tile程序确定的NLR和LMR截断值分别为5.7和1.1。
- NLR>5.7或LMR≤1.1的患者死亡率显著更高(P<0.001)。
- 开发队列多因素Cox分析中预测死亡率的独立因素为年龄(HR:1.064,95%CI:1.045-1.084,P<0.001)、NLR(HR:1.124,95%CI:1.091-1.158,P<0.001)和LMR(HR:0.794,95%CI:0.702-0.898,P<0.001)。
- 列线图预测生存的C指数高于MELD评分、MELD-Na和CLIF-C ADs评分,tdROC和决策曲线显示列线图优于MELD评分、MELD-Na和CLIF-C ADs评分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inflammation plays a vital role in liver cirrhosis progression and prognosis. AIM: To investigate the prognostic significance of inflammatory response markers in decompensated cirrhotic patients without acute-on-chronic liver failure (ACLF). METHODS: Independent predictors were identified using multivariate Cox model and then assembled into a nomogram to predict survival. Concordance index (C-index) and time-dependent receiver operating characteristics (td-ROC) analysis were adopted to evaluate and compare the performance of nomogram, model for end-stage liver disease (MELD) scores, MELD-Na and Chronic Liver Failure-consortium score for acute decompensated (CLIF-C ADs). RESULTS: A total of 902 decompensated cirrhotic patients with different aetiologies were enrolled, with 6-month, 1-year and 3-year mortality of 18.6%, 24.4% and 34.8%, respectively. The cut-off values for neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) determined by X-tile program were 5.7 and 1.1 respectively. Patients with NLR>5.7 or LMR≤1.1 had significantly higher mortality (P < 0.001). Independent factors derived from multivariable Cox analysis of development cohort to predict mortality were age, NLR and LMR (hazard ratio (HR): 1.064, 95% confidence interval (CI): 1.045-1.084, P < 0.001; HR: 1.124, 95%CI: 1.091-1.158, P < 0.001; HR: 0.794, 95%CI: 0.702-0.898, P < 0.001, respectively). The C-indexes of nomogram were higher than that of MELD score, MELD-Na and CLIF-C ADs for predicting survival. The tdROC and decision curves showed that nomogram was superior to MELD score, MELD-Na and CLIF-C ADs. Similar results were observed in validation cohort. CONCLUSION: The proposed nomogram with neutrophil-to-lymphocyte ratio and lymphocyte-to-monocyte ratio resulted in accurate prognostic prediction for decompensated cirrhotic patients without ACLF.
引用
- Cai YJ, Dong JJ, Dong JZ, et al. A nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute-on-chronic liver failure. Aliment Pharmacol Ther. 2017. PMID: 28345155. doi:10.1111/apt.14046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。